InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Browse the detailed record of transactions filed by Otto Dawn Parsell, Vice-Président Exécutif. Insider active across 1 company, notably Tricida, Inc.. Aggregated, 1 disclosures have been recorded. History available since 31 December 2021. The latest transaction was filed on 31 December 2021 (Retenue fiscale). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Otto Dawn Parsell
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报1 总计
1,574 股@ US$9.56100.0% 占其流量Common StockSEC:0001595585-22-000004:0
1 条申报中的 1 条
About Otto Dawn Parsell
Dawn Parsell Otto is the Executive Vice President of Clinical Development at Tricida, Inc. She is responsible for overseeing the company's clinical development programs and research strategy. Her expertise in the pharmaceutical field and experience in clinical project management are essential for the success of Tricida's initiatives. Dawn Otto is committed to advancing innovation in the healthcare sector.
